Adalimumab-ryvk
Active substance: adalimumab-ryvk
KIT · adalimumab-ryvk
United StatesActive
Marketing holder: Quallent Pharmaceuticals Health LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- adalimumab-ryvk
Registration
- Registration number
- 82009-156
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 82009-156 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 82009-156 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 82009-156 · Verified 2026-10-09 · open in source